Cardiac troponin in pediatric cardiology: toward standardized interpretive frameworks and clinical decision limits

What is it about?

Over the past 20 years, interest has grown in the clinical value of cardiac biomarkers for diagnosing and prognosticating a range of pediatric conditions. As recently confirmed, the key takeaway is the urgent need for pediatric-specific validation studies to establish appropriate interpretive frameworks, clinical decision limits, and outcome-driven guidance for cardiac troponin testing in children.

Featured Image